To our knowledge, there are only two previous published molecular studies of TSC patients in Mexico: one involving three patients with early-stage polycystic kidney disease that were molecularly confirmed to represent TSC2/PKD1 contiguous gene syndrome cases17 and one involving three TSC2-cases with prenatally documented cardiac rhabdomyomas18. This evidence concerns the gene PKD1 and polycystic kidney disease.